Summary
The prognostic value of the determinations of autoantibodies in Graves' disease is still questionable. So far, the role of different assay procedures used has not been intensively investigated. We simultaneously applied two different techniques, a radioreceptor assay and a T3 releasing in vitro assay, in the follow-up of patients with Graves' disease to directly compare the course of the antibody activities determined by these assays and to find out a prognostic significance of the composition of the antibody spectrum present. The initial activities of thyroid stimulating antibodies (TSAb) and TSH-binding inhibiting immunoglobulins (TBII) were not significantly correlated in patients before treatment. During a 12-month antithyroid medication antibody titres showed a concordant course in the majority of patients. In 6 of 25 patients, however, a discordant behaviour was clearly documented including dose-response curves. At the end of treatment, the patients could be divided into three groups: group I included 5 patients positive for both TSAb and TBII, group II 6 patients positive for TBII and negative for TSAb and group III 14 patients negative for both of them. During the following survey of 18 months all patients of group I, 2 patients of group II and 6 patients of group III experienced a relapse of hyperthyroidism. In conclusion, TSAb and TBII activities dissociate in some patients during antithyroid drug therapy. For the individual patient, the disappearance of both TSAb and TBII was no certain indicator for a longstanding remission of Graves' hyperthyroidism. The persistence of TSAb seems to be more reliably associated with persisting or rapidly relapsing disease than the persistence of TBII.
Similar content being viewed by others
Abbreviations
- cAMP:
-
Cyclic Adenosine Monophosphate
- GD:
-
Graves' disease
- T3:
-
Triiodothyronine
- T4:
-
Tetraiodothyronine
- TBII:
-
TSH-binding inhibiting immunoglobulins
- TRH:
-
TSH releasing hormone
- TSAb:
-
Thyroid stimulating antibodies
- TSH:
-
Thyroid stimulating hormone
References
Atkinson S, Kendall-Taylor P (1981) The stimulation of thyroid hormone secretion in vitro by thyroid-stimulating antibodies. J Clin Endocrinol Metab 53:1263–1266
Bech K, Madsen N (1980) Influence of treatment with radioiodine and propylthiouracil on thyroid stimulating immunoglobulins in Graves' disease. Clin Endocrinol 13:417–424
Bliddal H, Kirkegaard C, Siersbaek-Nielsen K, Friis T (1981) Prognostic value of thyrotrophin binding inhibiting immunoglobulins (TBII) in longterm antithyroid treatment,131I therapy given in combination with carbimazole and in euthyroid ophthalmopathy. Acta Endocrinol (Kbh) 98:364–369
Bliddal H, Bech K, Petersen PH, Siersbaek-Nielsen K, Friis T (1982) Evidence of a correlation between thyrotrophin receptor binding inhibition and thyroid adenylate cyclase activation by immunoglobulins in Graves' disease before and during long-term antithyroid treatment. Acta Endocrinol (Kbh) 101:35–40
Bliddal H, Bech K, Kirkegaard C (1984) Thyroid stimulating immunoglobulins in patients in long-term remission after Graves' disease. Horm Metab Res 16:602–605
Docter R, Bos G, Visser TJ, Henneman G (1980) Thyrotropin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator. Clin Endocrinol 12:143–153
Fenzi G, Hashizume K, Roudebush CP, DeGroot LJ (1979) Changes in thyroid-stimulating immunoglobulins during antithyroid therapy. J Clin Endocrinol Metab 48:572–576
Gossage AAR, Crawley JCW, Copping S, Hinge D, Himsworth RL (1983) Consistency and variability in the character of thyrotrophin receptor antibodies in Graves' disease. Clin Endocrinol 19:97–104
Hensen J, Kotulla P, Finke R, Bogner U, Badenhoop K, Meinhold H, Schleusener H (1984) Methodological aspects and clinical results of an assay for thyroid stimulating antibodies (TSAb) — Correlation with thyrotropin binding inhibiting antibodies (TBIAb). J Clin Endocrinol Metab 58:980–987
Hörmann R, Saller B, Müller R, Hobelsberger A, Moser E, Mann K (1985a) Methodische Probleme und klinische Wertigkeit der Bestimmung von TSH-Rezeptor-Antikörper mit einem kommerziellen Kit. Lab Med 9:208–213
Hörmann R, Müller R, Saller B, Mann K (1985) Similar triiodothyronine releasing activity of thyroid stimulating antibodies in human and porcine thyroid slices. Horm Metab Res (in press)
Islam MN, Pepper BM, Briones-Urbina R, Farid NR (1983) Biological activity of anti-thyrotropin anti-idiotypic antibody. Eur J Immunol 13:57–63
Kohn LD, Valente WA, Laccetti P, Cohen JL, Aloj SM, Grollman EF (1983) Multicomponent structure of the thyrotropin receptor: Relationship to Graves' Disease. Life Science 32:15–30
Macchia C, Fenzi GF, Monzani F, Lippi F, Vitti P, Grasso L, Bartalena L, Bascheri L, Pinchera A (1981) Comparison between thyroid stimulating and TSH-binding inhibiting immunoglobulins of Graves' disease. Clin Endocrinol 15:175–182
Madec AM, Laurent MC, Lorcy Y, LeGuerrieer AM, Rostagnat-Stefanutti A, Orgiazzi J, Allannic H (1984) Thyroid stimulating antibodies: An Aid to the strategy of Graves' disease? Clin Endocrinol 21:247–255
McGregor AM, Smith BR, Hall R (1980) Prediction of relapse in hyperthyroid Graves' disease. Lancet II:1101–1103
McGregor AM, Petersen MM, McLachlan SM, Smith BR, Hall R (1980) Treatment and the autoimmune response in Graves' disease. J Mol Med 4:119–127
Mukhtar ED, Smith BR, Pyle GA, Hall R, Vice P (1975) Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet II:713–715
Romaldini JH, Bromberg N, Werner RS, Farah CS, Reis LCF (1983) Comparison of effects of high and low dosage regimes of antithyroid drugs in the management of Graves' hyperthyroidism. J Clin Endocrinol Metab 57:563–570
Schleusener H, Finke R, Kotulla P, Wenzel KW, Meinhold H, Roedler HD (1978) Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease? J Endocrinol Invest 2:155–161
Shewring G, Smith BR (1982) An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol 17:409–417
Sugenoya A, Kidd A, Row VV, Volpe R (1979) Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other disorders. J Clin Endocrinol Metab 48:398–402
Teng CS, Yeung RTT (1980) Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: A prospective study. J Clin Endocrinol Metab 50:144–147
Zakarija M, McKenzie JM, Banovac K (1980) Clinical significance of assay of thyroid-stimulating antibody in Graves' disease. Ann Intern Med 93:28–32
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hörmann, R., Saller, B., Müller, R. et al. Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease. Klin Wochenschr 63, 1247–1252 (1985). https://doi.org/10.1007/BF01738449
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01738449